TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32506860

Group type: EXPERIMENTAL
Intervention: Thin wrist‐ankle acupuncture (WAA) + Fluoxetine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Thick wrist‐ankle acupuncture (WAA) + Fluoxetine
Number of subjects: 105

Group type: COMPARATOR
Intervention: Sham wrist‐ankle acupuncture (WAA) + Fluoxetine
Number of subjects: 105
Study: 35347429

Group type: EXPERIMENTAL
Intervention: Daytime-walking group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Night-time-walking group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Sun-exposure-only group
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All intervention groups
Number of subjects: 81
Study: 33434907

Group type: EXPERIMENTAL
Intervention: Lying-flat head positioning
Number of subjects: 8285

Group type: COMPARATOR
Intervention: Sitting-up head positioning
Number of subjects: 8285
Study: 32646462

Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa (CFA) with 300 UI rFSH and 150 UI rLH in long agonist protocol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corifollitropin alfa (CFA) with 300 UI rFSH and 150 UI rLH in short antagonist protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-CFA protocol
Number of subjects: 0
Study: 35140009

Group type: EXPERIMENTAL
Intervention: No postoperative x-ray (intervention group)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Standard postoperative x-ray (control group)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 316
Study: 34076580

Group type: EXPERIMENTAL
Intervention: Emotional messages
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Repeated messages
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Feeling personality types
Number of subjects: 89

Group type: COMPARATOR
Intervention: Logical messages
Number of subjects: 89

Group type: COMPARATOR
Intervention: No messages
Number of subjects: 89
Study: 35229427

Group type: EXPERIMENTAL
Intervention: Teneligliptin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35395080

Group type: EXPERIMENTAL
Intervention: Durvalumab + radiotherapy (cohort A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Durvalumab alone (cohort B)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Durvalumab + standard bevacizumab (cohort B2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Durvalumab + low-dose bevacizumab (cohort B3)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Durvalumab + bevacizumab (cohort C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dexamethasone use
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: CD8+Ki67+T cells at day 15
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: TMB and IAS
Number of subjects: 40
Study: 33979451

Group type: EXPERIMENTAL
Intervention: Fenfluramine (FFA) at 0.4 mg/kg/day (n=2) or 0.7 mg/kg/day (n=4; maximum: 26 mg/day) for a mean duration of 5.3 months (range: 2–9 months)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Fenfluramine (FFA)
Number of subjects: 6
Study: 32144531

Group type: EXPERIMENTAL
Intervention: Conservative sinusectomy (S)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Excision and paramedian primary closure (PC)
Number of subjects: 58
Study: 33279157

Group type: EXPERIMENTAL
Intervention: Presintered cobalt-chromium (Co-Cr) fixed partial dentures
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Presintered zirconia fixed partial dentures
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Premolar with Co-Cr
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Molar with zirconia
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both materials tested
Number of subjects: 12
Study: 33658470

Group type: EXPERIMENTAL
Intervention: Dietary supplement comprising 1197 mg of acetic acid bacteria containing 9.06 mg of ceramide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 32446158

Group type: EXPERIMENTAL
Intervention: Chatbot group (n = 21)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 41
Study: 35954756

Group type: EXPERIMENTAL
Intervention: High-Intensity Power Training (HIPT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Traditional Resistance Training (TRT)
Number of subjects: 24
Study: 34911462

Group type: EXPERIMENTAL
Intervention: Nomogram-1 based on INR and eGFR for 28-day mortality
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Nomogram-2 based on INR and eGFR for 90-day mortality
Number of subjects: 105

Group type: COMPARATOR
Intervention: Comparison with AARC, MELD, MELD-Na, and ALBI scores
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Calibration curve and Hosmer-Lemeshow test for Nomogram-1 and Nomogram-2
Number of subjects: 105
Study: 35065705

Group type: EXPERIMENTAL
Intervention: SCB-2019 vaccine (30 µg, adjuvanted with 1.50 mg CpG-1018 and 0.75 mg alum), administered as two 0.5 mL intramuscular doses 21 days apart.
Number of subjects: 30174

Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride for injection).
Number of subjects: 30174
Study: 34412307

Group type: EXPERIMENTAL
Intervention: Descriptor-based method combined with partition approach for 3D microstructure reconstruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3D reconstructed model
Number of subjects: 0
Study: 32223442

Group type: EXPERIMENTAL
Intervention: Self-affirming implementation intention
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Mental contrasting with self-affirming implementation intention
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Non-affirming implementation intention
Number of subjects: 198

Group type: COMPARATOR
Intervention: Inactive control group
Number of subjects: 198
Study: 33768772

Group type: EXPERIMENTAL
Intervention: Upper limb neuromuscular electrical stimulation (NMES)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lower limb neuromuscular electrical stimulation (NMES)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Comparison of metaboreflex activation between upper and lower limbs
Number of subjects: 20
Study: 34941131

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg/d
Number of subjects: 46

Group type: COMPARATOR
Intervention: Bisoprolol 10 mg/d
Number of subjects: 46
Study: 34982767

Group type: EXPERIMENTAL
Intervention: Audit/feedback retained, incentives removed (group A)
Number of subjects: 49525

Group type: EXPERIMENTAL
Intervention: Incentives retained, audit/feedback removed (group B)
Number of subjects: 49525

Group type: EXPERIMENTAL
Intervention: Both removed (group C)
Number of subjects: 49525

Group type: EXPERIMENTAL
Intervention: Both retained (group D)
Number of subjects: 49525

Group type: COMPARATOR
Intervention: Audit/feedback removed
Number of subjects: 49525
Study: 32683383

Group type: EXPERIMENTAL
Intervention: Ozonized water treatment
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo treatment (double‐distilled water)
Number of subjects: 51
Study: 36105927

Group type: EXPERIMENTAL
Intervention: Physical exercise (jogging, basketball, and outdoor training) for 12 weeks, three times per week.
Number of subjects: 46
Study: 33913549

Group type: EXPERIMENTAL
Intervention: Aspirin administration
Number of subjects: 991
Study: 32861358

Group type: EXPERIMENTAL
Intervention: Fascial therapy (3 weeks, 45 minutes per week)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Fascial therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 65
Study: 34045486

Group type: EXPERIMENTAL
Intervention: Convalescent plasma containing high titers of neutralizing SARS‐CoV‐2 antibodies (300mL)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 86
Study: 32017358

Group type: EXPERIMENTAL
Intervention: ROVOT (robotically operated video optical telescopic-microscope)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Microscope
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ROVOT
Number of subjects: 0
Study: 33951265

Group type: EXPERIMENTAL
Intervention: Extensive stenting (TSL >100 mm)
Number of subjects: 1758

Group type: EXPERIMENTAL
Intervention: Small stenting (ASD <3 mm)
Number of subjects: 1758

Group type: COMPARATOR
Intervention: Not-extensive and large stents
Number of subjects: 1758

Group type: EXPERIMENTAL
Intervention: Total stent length (TSL) as a continuous variable
Number of subjects: 1758

Group type: EXPERIMENTAL
Intervention: Average nominal stent diameter (ASD) as a continuous variable
Number of subjects: 1758
Study: 32041656

Group type: COMPARATOR
Intervention: Standard package of support from community health workers (CHWs) during home visits, focused on the individual (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention focusing on both the individual and the household to enable self-management of treatment within an HIV competent household (Intervention)
Number of subjects: 0
Study: 34861374

Group type: EXPERIMENTAL
Intervention: Veliparib monotherapy (300-400 mg twice daily)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo monotherapy
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Veliparib during combination therapy and monotherapy
Number of subjects: 194

Group type: COMPARATOR
Intervention: Veliparib and placebo monotherapy
Number of subjects: 194
Study: 35228754

Group type: EXPERIMENTAL
Intervention: empagliflozin 10 mg once daily
Number of subjects: 530

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 530
Study: 32696816

Group type: EXPERIMENTAL
Intervention: Brazilian-Portuguese version of the Sleep Apnea Clinical Score (SACS) applied in 86 patients who underwent polysomnography.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Pre-test phase with consensus version of SACS applied in 20 patients.
Number of subjects: 106
Study: 35794587

Group type: EXPERIMENTAL
Intervention: Iron biofortified pearl millet (BPM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard grain (pearl millet) (CPM)
Number of subjects: 0
Study: 34831683

Group type: EXPERIMENTAL
Intervention: Night shift work
Number of subjects: 74
Study: 34203356

Group type: EXPERIMENTAL
Intervention: Genetically predicted coffee consumption (per 50% increase)
Number of subjects: 53004
Study: 35791471

Group type: EXPERIMENTAL
Intervention: Sodium oligomannate (GV-971)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Donepezil
Number of subjects: 72
Study: 33360477

Group type: EXPERIMENTAL
Intervention: Fitspiration
Number of subjects: 331

Group type: EXPERIMENTAL
Intervention: Thinspiration
Number of subjects: 331

Group type: COMPARATOR
Intervention: Travel images
Number of subjects: 331
Study: 33260699

Group type: EXPERIMENTAL
Intervention: Educational training program for healthcare professionals (20 hours)
Number of subjects: 145

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 145
Study: 33819498

Group type: EXPERIMENTAL
Intervention: Etomidate 0.03 mg/kg
Number of subjects: 50

Group type: COMPARATOR
Intervention: Propofol 0.2 mg/kg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Etomidate and Propofol)
Number of subjects: 50
Study: 33631623

Group type: EXPERIMENTAL
Intervention: Linseed oil (LO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soybean oil (SO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palm oil (PO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (CO)
Number of subjects: 0
Study: 33933353

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment, 2 sessions at 3-week intervals
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sham IPL treatment (Control)
Number of subjects: 76
Study: 33225554

Group type: EXPERIMENTAL
Intervention: Withdrawing therapy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Withdrawing therapy (non-randomized comparison)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Withdrawing therapy (among those who did not relapse)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Withdrawing therapy (in patients with TTN variants)
Number of subjects: 48
Study: 36000187

Group type: EXPERIMENTAL
Intervention: Animation education
Number of subjects: 66

Group type: COMPARATOR
Intervention: Routine face-to-face education
Number of subjects: 66
Study: 33586858

Group type: EXPERIMENTAL
Intervention: Home-based multimodal exercise program (60-min sessions, three times a week for 16 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 32498699

Group type: EXPERIMENTAL
Intervention: Flexible ureterorenoscopy (FURS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extracorporeal shockwave lithotripsy (ESWL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous nephrolithotomy (PCNL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FURS, ESWL, or PCNL
Number of subjects: 0
Study: 35995638

Group type: EXPERIMENTAL
Intervention: Driving pressure group (n=650) with alveolar recruitment/individualised PEEP
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Conventional protective ventilation group (n=650) with fixed PEEP of 5 cm H2O
Number of subjects: 1300
Study: 34959836

Group type: EXPERIMENTAL
Intervention: Shatavari (1000 mg/d for 6 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 35662619

Group type: EXPERIMENTAL
Intervention: Reward Re‐Training (RRT) treatment for 10 weeks
Number of subjects: 23

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 23
Study: 32495667

Group type: EXPERIMENTAL
Intervention: Functional Magnetic Stimulation (FMS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low-frequency repetitive transcranial magnetic stimulation (LF-rTMS)
Number of subjects: 40
Study: 34612491

Group type: EXPERIMENTAL
Intervention: UCT + LNS
Number of subjects: 1729

Group type: EXPERIMENTAL
Intervention: UCT + LNS + SBCC
Number of subjects: 1729

Group type: COMPARATOR
Intervention: UCT + SBCC
Number of subjects: 1729

Group type: COMPARATOR
Intervention: UCT
Number of subjects: 1729
Study: 33535507

Group type: EXPERIMENTAL
Intervention: Exercise group (moderate-intensity combined aerobic, resistance and flexibility exercises three times a week for eight weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no specific information regarding exercise)
Number of subjects: 57
Study: 33902773

Group type: EXPERIMENTAL
Intervention: Tier 2 intervention implemented by teachers with training in RtI components
Number of subjects: 1923

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1923

Group type: EXPERIMENTAL
Intervention: Intervention timing
Number of subjects: 1923
Study: 33415859

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (nape seven needles combined with penetration needling for 30 min, once daily for 4 weeks)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Flunarizine hydrochloride capsules (5 mg, once daily for 4 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Total effective rate of treatment group
Number of subjects: 116
Study: 35791050

Group type: EXPERIMENTAL
Intervention: 2‐d FAST with two 10‐min CWI
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 2‐d FAST without CWI
Number of subjects: 13

Group type: COMPARATOR
Intervention: 2‐d two CWI without FAST
Number of subjects: 13

Group type: COMPARATOR
Intervention: 2‐d usual diet without CWI
Number of subjects: 13
Study: 32501774

Group type: EXPERIMENTAL
Intervention: Alcaftadine 0.25%
Number of subjects: 263

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 263

Group type: COMPARATOR
Intervention: Olopatadine 0.1%
Number of subjects: 263
Study: 32533236

Group type: EXPERIMENTAL
Intervention: Bracka staged repair (Group A)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Byar’s staged repair (Group B)
Number of subjects: 142
Study: 36260404

Group type: EXPERIMENTAL
Intervention: Instrumented shoe insole
Number of subjects: 35

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study: 34647191

Group type: EXPERIMENTAL
Intervention: RF + PEMF
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 32
Study: 34762375

Group type: EXPERIMENTAL
Intervention: XingnaoKaiqiao acupuncture (once a day, 5 days per week, for 30 days)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group treatment (rehabilitation and hyperbaric oxygen)
Number of subjects: 100
Study: 32424726

Group type: EXPERIMENTAL
Intervention: Compression Garments (CG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (normal clothing)
Number of subjects: 30
Study: 35081935

Group type: EXPERIMENTAL
Intervention: Mobile social networking
Number of subjects: 110

Group type: COMPARATOR
Intervention: Text messaging
Number of subjects: 110
Study: 34164935

Group type: EXPERIMENTAL
Intervention: Khanya intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Enhanced Treatment as Usual (ETAU)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study: 32293738

Group type: EXPERIMENTAL
Intervention: Oslo Sports Trauma Research Center shoulder injury prevention program (conducted 3 times per week for 18 weeks)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Oslo Sports Trauma Research Center shoulder injury prevention program
Number of subjects: 57
Study: 34802087

Group type: EXPERIMENTAL
Intervention: Nomogram developed based on multivariable logistic regression analysis using predictors such as glucocorticoid injection history, knee OA in the contralateral side, extensor muscle strength, area of cartilage deficiency, bone marrow lesion, and meniscus extrusion.
Number of subjects: 839
Study: 33574013

Group type: EXPERIMENTAL
Intervention: Double-headed capsule endoscopy (DH CE)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Single-headed capsule endoscopy (SH CE)
Number of subjects: 204
Study: 34636838

Group type: EXPERIMENTAL
Intervention: Prolonged release tapentadol
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34309491

Group type: EXPERIMENTAL
Intervention: Bisphosphonate treatment (pamidronate, alendronate, ibandronate)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Bisphosphonate treatment
Number of subjects: 10
Study: 35924008

Group type: EXPERIMENTAL
Intervention: UDCA (13–15 mg/kg/day) + fenofibrate (200 mg/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: UDCA (13–15 mg/kg/day)
Number of subjects: 48
Study: 34087055

Group type: EXPERIMENTAL
Intervention: Skin whitening serum containing niacinamide, hydroxyphenoxy propionic acid, dipotassium glycyrrhizate, glycolic acid, and 4‐n‐butylresorcinol applied twice daily combined with a spot‐preventing SPF50+ sunscreen
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Skin whitening serum
Number of subjects: 12
Study: 34781972

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine and perioperative gabapentin (ITM+GABA group)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intrathecal morphine only (ITM group)
Number of subjects: 50
Study: 33338644

Group type: EXPERIMENTAL
Intervention: Vitamin K antagonists (VKA)
Number of subjects: 17465

Group type: COMPARATOR
Intervention: No specific intervention reported
Number of subjects: 17465
Study: 32037134

Group type: EXPERIMENTAL
Intervention: internet‐based cognitive‐behavioural writing therapy (iCBT) for PTSD
Number of subjects: 2
Study: 33632478

Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CTA)
Number of subjects: 978

Group type: COMPARATOR
Intervention: Invasive coronary angiography (ICA)
Number of subjects: 978
Study: 32372689

Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Never treated with lithium
Number of subjects: 131

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 131
Study: 35722557

Group type: EXPERIMENTAL
Intervention: Two different therapeutic interventions (specifics not provided)
Number of subjects: 0
Study: 34508547

Group type: EXPERIMENTAL
Intervention: DMARD tapering arms
Number of subjects: 108

Group type: COMPARATOR
Intervention: Continuation of DMARDs
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Both IgA and IgG ACPA
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: IgA2 ACPA levels
Number of subjects: 108
Study: 35622221

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study: 34009911

Group type: EXPERIMENTAL
Intervention: Shorter training intervals (1 or 7 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Longer training intervals (30 or 90 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-month interval refreshers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPO (personalized interval refreshers)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 6-month interval refreshers
Number of subjects: 0
Study: 33978160

Group type: EXPERIMENTAL
Intervention: Fatty fish (herring/mackerel)
Number of subjects: 232
Study: 32736578

Group type: EXPERIMENTAL
Intervention: Brief Motivational Treatment (BMT) - four 45-min sessions provided by a general psychologist with at least 3 years of primary care experience.
Number of subjects: 182

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Brief Motivational Treatment (BMT)
Number of subjects: 182
Study: 36069870

Group type: EXPERIMENTAL
Intervention: Closed-loop therapy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control therapy
Number of subjects: 97
Study: 33711081

Group type: EXPERIMENTAL
Intervention: Subthalamic nucleus deep brain stimulation (STN‐DBS)
Number of subjects: 0
Study: 35490437

Group type: EXPERIMENTAL
Intervention: EEG recording latency
Number of subjects: 364
Study: 33959986

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 33362714

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing intervention during appointments every 4 months with the endocrinologist
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group with usual appointments
Number of subjects: 66
Study: 35279220

Group type: EXPERIMENTAL
Intervention: CO2-laser irradiation in combination with fluoride therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluoride therapy alone
Number of subjects: 0
Study: 34381108

Group type: EXPERIMENTAL
Intervention: EPA (3 g/d)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: DHA (3 g/d)
Number of subjects: 21

Group type: COMPARATOR
Intervention: High oleic acid sunflower oil (3 g/day, baseline)
Number of subjects: 21